165 related articles for article (PubMed ID: 1708881)
1. [Epithelial markers of 2 cytokeratin-negative small cell bronchial cancers].
Bohrer MH; Hastka J
Pathologe; 1991 Jan; 12(1):21-3. PubMed ID: 1708881
[No Abstract] [Full Text] [Related]
2. Small cell carcinoma of the parotid. Fine needle aspiration and immunochemical findings in a case.
Cameron WR; Johansson L; Tennvall J
Acta Cytol; 1990; 34(6):837-41. PubMed ID: 1701603
[TBL] [Abstract][Full Text] [Related]
3. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors.
Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J
Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900
[TBL] [Abstract][Full Text] [Related]
4. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
Förster C; Bässler R
Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
[No Abstract] [Full Text] [Related]
5. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma.
Miettinen M
Arch Pathol Lab Med; 1988 Jun; 112(6):637-40. PubMed ID: 2454091
[TBL] [Abstract][Full Text] [Related]
6. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
7. Expression of cytokeratin and neuron-specific enolase in small cell carcinomas of the lung.
Kitinya JN; Kingo M; Tanaka K
Histol Histopathol; 1987 Oct; 2(4):333-43. PubMed ID: 2485219
[TBL] [Abstract][Full Text] [Related]
8. [In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?].
Jany B; Fischbach W; Chowanetz W
Med Klin (Munich); 1988 Feb; 83(4):121-4, 158. PubMed ID: 3367874
[No Abstract] [Full Text] [Related]
9. [Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage].
von Eiff M; Koch O; Appelhans N; Roos N; van de Loo J
Pneumologie; 1990 Feb; 44 Suppl 1():462-4. PubMed ID: 2164198
[TBL] [Abstract][Full Text] [Related]
10. Detection of cytoskeletal proteins in small cell lung carcinoma.
Hlozánková M; Lukás Z; Viklický V
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():47-9. PubMed ID: 10707834
[TBL] [Abstract][Full Text] [Related]
11. [HEA125 and BerEP4 in neuro-oncologic differential diagnosis].
Gottschalk J; Jautzke G; Zimmer C; Paulus W; Cervos-Navarro J
Pathologe; 1992 Apr; 13(2):95-9. PubMed ID: 1603778
[No Abstract] [Full Text] [Related]
12. [Tumor markers in the diagnosis and follow-up assessment of bronchial carcinoma].
Fischbach W
Dtsch Med Wochenschr; 1989 May; 114(20):800-5. PubMed ID: 2656177
[No Abstract] [Full Text] [Related]
13. Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts.
Bak M; Mattern J; Volm M
In Vivo; 1987; 1(5):319-26. PubMed ID: 2485134
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of epithelial marker expression in routinely processed, poorly differentiated carcinomas.
Kamel OW; Rouse RV; Warnke RA
Arch Pathol Lab Med; 1991 Jun; 115(6):566-70. PubMed ID: 1710100
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
Bobos M; Hytiroglou P; Kostopoulos I; Karkavelas G; Papadimitriou CS
Am J Dermatopathol; 2006 Apr; 28(2):99-104. PubMed ID: 16625069
[TBL] [Abstract][Full Text] [Related]
17. [Iliac crest aspiration in the assessment of bone marrow involvement in small-cell bronchial carcinoma is sufficient].
Wulf G; Hiddemann W
Strahlenther Onkol; 1995 Sep; 171(9):544-5. PubMed ID: 7570305
[No Abstract] [Full Text] [Related]
18. [Which tumor markers should be used in primary bronchial cancers?].
Schuller MP; Carrat F; Urban T; Lebeau B
Rev Mal Respir; 1997 Apr; 14 Suppl 3():S9-14. PubMed ID: 9229750
[No Abstract] [Full Text] [Related]
19. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
[TBL] [Abstract][Full Text] [Related]
20. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
Eberlein-Gonska M; Wiedenmann B; Waldherr R
Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
